Thursday, July 18, 2013

Manipulating California electricity prices costs Barclays Bank $453

[unable to retrieve full-text content]

Source: www.bizjournals.com --- Tuesday, July 16, 2013
The Federal Energy Regulatory Commission on Tuesday ordered Barclays Bank PLC and four of its traders to pay a fine of $453 million for manipulating California electricity prices. The price manipulation occurred in California and other Western states between November 2006 and December 2008. The federal agency also ordered Barclays to disgorge $34.9 million ? plus interest ? in ill-gotten gains related to the Low-Income Home Energy Assistance Programs of Arizona, California, Oregon and Washington. The? ...

Source: http://feedproxy.google.com/~r/vertical_13/~3/L9TNUeCgcSc/barclays-bank-fined-453m-for.html

black panthers mauritania obama open mic jefferson county colorado extenze tenacious d steve smith

Wednesday, July 17, 2013

Post-testimony legal wrangling begins in Manning case ? CNN ...

By CNN Pentagon Producer Larry Shaughnessy

FORT MEADE, Maryland (CNN) - After years of pretrial delays and legal battles, testimony in the court-martial trial of Pfc. Bradley Manning is all but over but the delays and battles continue.

Last Monday, before presenting witnesses in the case, Manning's defense attorneys filed motions asking the military judge, Col. Denise Lind, to find him not guilty of four of the charges against him.

Among those four charges they want the judge to consider is the most serious charge against Manning, aiding the enemy. If he's found guilty of that charge, he faces a maximum penalty of life in prison.

Manning's attorneys maintain that the prosecutors in the case failed to show "that Pfc. Manning had 'actual knowledge' that by giving information to WikiLeaks, he was giving information to an enemy of the United States," according to the defense motion.

According to David Coombs, Manning's lead attorney, the prosecution contends "if you give information to any news organization that is going to publish it on the Internet, you are giving it to the enemy."

The defense presented evidence earlier in the case that they said showed there are intelligence gaps regarding whether terrorist groups such as al Qaeda go to WikiLeaks for information about the U.S. military.

"What better proof that Pfc. Manning didn't know if the enemy goes to WikiLeaks than the U.S. Army doesn't know if the enemy goes to WikiLeaks," Coombs said.

"Pfc. Manning had the ability to send the information directly to the enemy if he had wanted to, but he didn't. He wanted to spark debate," Coombs told the judge.

Prosecutors maintain that Manning based on his training and work as an intelligence analyst "should have known" that putting information on the internet was providing information to the enemy.

Most of the first couple of hours of Monday's court hearing were spent debating another defense motion regarding accusations that Manning loaded a computer program called WGet on his work computer in Iraq.

The government maintains that the program was not authorized and allowed him to quickly download huge caches of files that eventually ended up on WikiLeaks.

The defense pointed out that several witnesses testified that WGet was not specifically banned and that several other kinds of programs, such as music programs, were not authorized but were allowed by the chain of command.
Lind said she would rule on both issues after court resumes at 9:30 a.m. Thursday. But that won't be the end of everything.

The judge ruled late Monday that the prosecutors would be allowed to present four rebuttal witness in response to some defense testimony.

Source: http://security.blogs.cnn.com/2013/07/15/post-testimony-legal-wrangling-begins-in-manning-case/

Jimmy Hoffa Rick Rubin The Wolf of Wall Street marilyn monroe MAC Cosmetics The Voice Results Miss USA 2013

York physicists offer novel insight into experimental cancer treatment

Posted on 15 July 2013

Physicists from the University of York have carried out new research into how the heating effect of an experimental cancer treatment works.

A Transmission Electron Microscope (TEM) image of the new particles produced by Liquids Research Ltd for hyperthermia applications.

Magnetic hyperthermia is viewed as an attractive approach for the treatment of certain cancers as it has no known side effects compared to more conventional therapies such as chemotherapy. It is particularly suitable for the treatment of prostate cancer and brain tumours. However, until now there has been no clear theoretical understanding of how it actually works.

Treatment by magnetic hyperthermia involves injecting magnetic nanoparticles directly into a tumour then placing the patient in a machine which produces an alternating magnetic field. The nanoparticles oscillate and heat is produced inside the tumour tissue. When the temperature rises above 42?C cells begin to die. This heating process has been demonstrated to reduce tumour size.

The study, by researchers from the University of York?s Department of Physics and Liquids Research Ltd, of Bangor, North Wales, showed that the amount of heat generated by magnetic nanoparticles can be understood when both the physical and hydrodynamic size distributions for the samples are known to high accuracy.

Through our study we have produced the first comprehensive assessment of how the heating effect in magnetic hyperthermia works

Dr Gonzalo Vallejo-Fernandez

The results of the study are published in the Journal of Physics D: Applied Physics as a fast track communication.

Lead author Dr Gonzalo Vallejo-Fernandez, from York?s Department of Physics, said: ?While clinical trials have shown the potential of magnetic nanoparticles for cancer treatment, the mechanisms by which the heat is generated have not been fully understood. This understanding is critical to produce particles with optimised properties for specific applications at minimal dose.?

Previously the heat generated was impossible to predict as several mechanisms were involved.? The new work has identified and quantified the mechanisms so that work can now begin to determine the dosage required for effective treatment.

Dr Vallejo-Fernandez said: ?Through our study we have produced the first comprehensive assessment of how the heating effect in magnetic hyperthermia works. We are now in a position where we can do further work to calculate accurately the dose of magnetic nanoparticles and length of treatment required.?

For the study, the researchers used magnetic nanoparticles produced by a new technique by Liquids Research Ltd, which was developed under the EU project MULTIFUN (Multifunctional Nanotechnology for Selective Detection and Treatment of Cancer). The nanoparticles are very uniform in size and well separated, which enabled detailed experiments to be performed which broadly confirmed the accuracy of the calculations.

Dr Vijay Patel, Director of Liquids Research Ltd, said: ?The development of this new theory coincided with our work on the new process to fabricate the nanoparticles enabling us to ?design? almost ideal particles for this application.?

  • The paper ?Mechanisms of Hyperthermia in Magnetic Nanoparticles? appears in Journal of Physics D: Applied Physics as a fast track communication. http://iopscience.iop.org/0022-3727/46/31/312001
  • The authors are Gonzalo Vallejo-Fernandez, Oliver Whear, Alejandro Gomez Roca (University of York); Susanna Hussain, James Timmis and Vijay Patel, (Liquids Research Ltd, Bangor); and Kevin O?Grady (University of York and Liquids Research Ltd). University of York undergraduate student Oliver Whear worked on the measurements during an Institute of Physics funded vacation research project.
  • Dr Gonzalo Vallejo-Fernandez can be contacted on gonzalo.vallejofernandez@york.ac.uk
  • A Transmission Electron Microscope (TEM) image of the new particles produced by Liquids Research Ltd for hyperthermia applications is available upon request. Please contact?pressoffice@york.ac.uk
  • For further information about the University of York?s Department of Physics, visit www.york.ac.uk/physics
  • For more information on Liquids Research UK visit www.liquidsresearch.com

Source: http://feedproxy.google.com/~r/uni-of-york-news/~3/EGcRCsE_cNc/

st louis news correspondents dinner i am legend san antonio spurs greta van susteren the five year engagement chris kreider

Bachmann aide charged with rash of thefts in House office building (Star Tribune)

Share With Friends: Share on FacebookTweet ThisPost to Google-BuzzSend on GmailPost to Linked-InSubscribe to This Feed | Rss To Twitter | Politics - Top Stories Stories, RSS Feeds and Widgets via Feedzilla.

Source: http://news.feedzilla.com/en_us/stories/politics/top-stories/319555896?client_source=feed&format=rss

Tropical Storm Sandy W S B H c mitt romney

Washington-Marion forward Mark Vital discusses his early recruitment

Registration on or use of this site constitutes acceptance of our User Agreement and Privacy Policy (Revised December 4, 2012)

? 2013 NOLA Media Group. All rights reserved (About Us).
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of NOLA Media Group.

Community Rules apply to all content you upload or otherwise submit to this site. Contact interactivity management.

Ad Choices

Source: http://videos.nola.com/times-picayune/2013/07/washington-marion_forward_mark.html

atari breakout Amys Baking Company oj simpson chicago bulls ncis how i met your mother tesla

Tuesday, July 16, 2013

BioTech News Headlines - Yahoo! News

BioTech News Headlines - Yahoo! Newshttp://news.yahoo.com/biotech/ Get the latest Biotech news headlines from Yahoo! News. Find breaking Biotech news, including analysis and opinion on top Biotech stories, photos and more.en-USCopyright (c) 2013 Yahoo! Inc. All rights reservedMon, 15 Jul 2013 12:00:50 -04005BioTech News Headlines - Yahoo! Newshttp://news.yahoo.com/biotech/ http://l.yimg.com/a/i/us/nws/th/main_142c.gifScientists find how "obesity gene" makes people fatBy Ben Hirschler LONDON (Reuters) - Scientists have unraveled how a gene long associated with obesity makes people fat by triggering increased hunger, opening up potential new ways to fight a growing global health problem. A common variation in the FTO gene affects one in six of the population, making them 70 percent more likely to become obese - but until now experts did not know why. ...http://news.yahoo.com/scientists-obesity-gene-makes-people-fat-160050035.htmlMon, 15 Jul 2013 12:00:50 -0400Reutersscientists-obesity-gene-makes-people-fat-160050035Alnylam bets on 'gene silencing' to woo biotech investorsBy Esha Dey and Pallavi Ail (Reuters) - A radical new treatment for genetic disorders has catapulted Alnylam Pharmaceuticals Inc into the crosshairs of investors seeking the next breakthrough name in biotechnology. The challenge for the Cambridge, Massachusetts-based company now is to prove that its 'gene silencing' technology can make the leap from the laboratory to the doctor's office and eclipse an alternative therapy already in use. Investors, for now, are betting that it will. A steady drip of positive trial data has helped to triple Alnylam's market value to more than $2. ...http://news.yahoo.com/alnylam-bets-gene-silencing-woo-biotech-investors-144723013.htmlFri, 12 Jul 2013 10:47:23 -0400Reutersalnylam-bets-gene-silencing-woo-biotech-investors-144723013Alnylam drug found effective in treating rare genetic disease(Reuters) - Alnylam Pharmaceuticals Inc said an early-stage trial of its gene-based therapy showed the drug was effective in suppressing a protein that causes a rare organ-damaging hereditary disorder. Alnylam shares rose 14 percent to $42.80 in premarket trade. The study was testing a subcutaneously administered version of the drug, ALN-TTR, to treat genetic disorder amyloidosis, which is caused by deposits of protein in tissues and organs. ...http://news.yahoo.com/alnylam-drug-found-effective-treating-rare-genetic-disease-132403151.htmlThu, 11 Jul 2013 09:24:03 -0400Reutersalnylam-drug-found-effective-treating-rare-genetic-disease-132403151Myriad sues competitor overs cancer gene testMyriad Genetics Inc. is suing two privately-held competitors to stop it from selling a genetic test that competes with Myriad's BRACAnalysis breast and ovarian cancer test. Myriad says Ambry Genetics Corp. ...http://news.yahoo.com/myriad-sues-competitor-overs-cancer-223108993.htmlWed, 10 Jul 2013 18:31:08 -0400Associated Pressmyriad-sues-competitor-overs-cancer-223108993Myriad sues competitor over cancer gene testMyriad Genetics Inc. is suing a privately-held competitor to stop it from selling a genetic test that competes with Myriad's BRACAnalysis breast and ovarian cancer test. Myriad says Ambry Genetics Corp. ...http://news.yahoo.com/myriad-sues-competitor-over-cancer-205137780.htmlWed, 10 Jul 2013 16:51:37 -0400Associated Pressmyriad-sues-competitor-over-cancer-205137780First child to receive windpipe grown from own stem cells dies<p><a href="http://news.yahoo.com/first-child-receive-windpipe-grown-own-stem-cells-160616412.html"><img src="http://l1.yimg.com/bt/api/res/1.2/GFPuq_Gz_TFcEb7GGPwOlg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-09T163904Z_1_CBRE9681A9700_RTROPTP_2_USA-ILLINOIS-STEMCELL.JPG" width="130" height="86" alt="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" align="left" title="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" border="0" /></a>By Chris Francescani (Reuters) - Two-year-old Hannah Warren, the first child to receive a windpipe grown from her own stem cells, has died three months after a rare operation, the Children&#039;s Hospital of Illinois in Peoria said. The child was diagnosed with an uncommon congenital abnormality known as tracheal agenesis, which means her windpipe failed to develop. She could not talk, eat or swallow on her own, according to a website by her parents, Darryl and Young-Mi Warren. ...</p><br clear="all"/>http://news.yahoo.com/first-child-receive-windpipe-grown-own-stem-cells-160616412.htmlTue, 09 Jul 2013 13:10:48 -0400Reutersfirst-child-receive-windpipe-grown-own-stem-cells-160616412<p><a href="http://news.yahoo.com/first-child-receive-windpipe-grown-own-stem-cells-160616412.html"><img src="http://l1.yimg.com/bt/api/res/1.2/GFPuq_Gz_TFcEb7GGPwOlg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-09T163904Z_1_CBRE9681A9700_RTROPTP_2_USA-ILLINOIS-STEMCELL.JPG" width="130" height="86" alt="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" align="left" title="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" border="0" /></a>By Chris Francescani (Reuters) - Two-year-old Hannah Warren, the first child to receive a windpipe grown from her own stem cells, has died three months after a rare operation, the Children&#039;s Hospital of Illinois in Peoria said. The child was diagnosed with an uncommon congenital abnormality known as tracheal agenesis, which means her windpipe failed to develop. She could not talk, eat or swallow on her own, according to a website by her parents, Darryl and Young-Mi Warren. ...</p><br clear="all"/>2 stem cell patients stop HIV drugs, no virus seen<p><a href="http://news.yahoo.com/2-stem-cell-patients-stop-hiv-drugs-no-112746486.html"><img src="http://l3.yimg.com/bt/api/res/1.2/d8LencqPZ80U5zMMq9YShw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/427a1fd937878116360f6a706700835f.jpg" width="130" height="86" alt="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" align="left" title="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" border="0" /></a>KUALA LUMPUR, Malaysia (AP) ? Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday.</p><br clear="all"/>http://news.yahoo.com/2-stem-cell-patients-stop-hiv-drugs-no-112746486.htmlWed, 03 Jul 2013 07:36:09 -0400Associated Press2-stem-cell-patients-stop-hiv-drugs-no-112746486<p><a href="http://news.yahoo.com/2-stem-cell-patients-stop-hiv-drugs-no-112746486.html"><img src="http://l3.yimg.com/bt/api/res/1.2/d8LencqPZ80U5zMMq9YShw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/427a1fd937878116360f6a706700835f.jpg" width="130" height="86" alt="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" align="left" title="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" border="0" /></a>KUALA LUMPUR, Malaysia (AP) ? Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday.</p><br clear="all"/>Scientists create human liver from stem cellsBy Kate Kelland LONDON (Reuters) - Scientists have for the first time created a functional human liver from stem cells derived from skin and blood and say their success points to a future where much-needed livers and other transplant organs could be made in a laboratory. While it may take another 10 years before lab-grown livers could be used to treat patients, the Japanese scientists say they now have important proof of concept that paves the way for more ambitious organ-growing experiments. ...http://news.yahoo.com/scientists-create-human-liver-stem-cells-033554646.htmlWed, 03 Jul 2013 23:35:54 -0400Reutersscientists-create-human-liver-stem-cells-033554646Stem-cell therapy wipes out HIV in two patientsBy Ben Hirschler LONDON (Reuters) - Two men with HIV have been off AIDS drugs for several months after receiving stem-cell transplants for cancer that appear to have cleared the virus from their bodies, researchers reported on Wednesday. Both patients, who were treated in Boston and had been on long-term drug therapy to control their HIV, received stem-cell transplants after developing lymphoma, a type of blood cancer. ...http://news.yahoo.com/stem-cell-therapy-wipes-hiv-two-patients-115302059.htmlWed, 03 Jul 2013 07:53:02 -0400Reutersstem-cell-therapy-wipes-hiv-two-patients-115302059World Food Prize goes to 3 biotech scientists<p><a href="http://news.yahoo.com/world-food-prize-goes-3-170632624.html"><img src="http://l1.yimg.com/bt/api/res/1.2/KhghTjhCNUmZ9Q_xzFkPtA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://globalfinance.zenfs.com/images/US_AHTTP_AP_FINANCIALTIMES/28f0b2d288923914350f6a706700cc56_original.jpg" width="130" height="86" alt="World Food Prize goes to 3 biotech scientists" align="left" title="World Food Prize goes to 3 biotech scientists" border="0" /></a>The World Food Prize Foundation on Wednesday took the bold step of awarding this year&#039;s prize to three pioneers of plant biotechnology whose work brought the world genetically modified crops. The private ...</p><br clear="all"/>http://news.yahoo.com/world-food-prize-goes-3-170632624.htmlWed, 19 Jun 2013 14:39:54 -0400Associated Pressworld-food-prize-goes-3-170632624<p><a href="http://news.yahoo.com/world-food-prize-goes-3-170632624.html"><img src="http://l1.yimg.com/bt/api/res/1.2/KhghTjhCNUmZ9Q_xzFkPtA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://globalfinance.zenfs.com/images/US_AHTTP_AP_FINANCIALTIMES/28f0b2d288923914350f6a706700cc56_original.jpg" width="130" height="86" alt="World Food Prize goes to 3 biotech scientists" align="left" title="World Food Prize goes to 3 biotech scientists" border="0" /></a>The World Food Prize Foundation on Wednesday took the bold step of awarding this year&#039;s prize to three pioneers of plant biotechnology whose work brought the world genetically modified crops. The private ...</p><br clear="all"/>Bluebird Bio shares rocket higher in trading debutNEW YORK (AP) ? Shares of gene therapy developer Bluebird Bio Inc. surged in their trading debut.http://news.yahoo.com/bluebird-bio-shares-rocket-higher-trading-debut-152519370.htmlWed, 19 Jun 2013 19:12:45 -0400Associated Pressbluebird-bio-shares-rocket-higher-trading-debut-152519370Court ruling may open up breast cancer gene tests<p><a href="http://news.yahoo.com/court-ruling-may-open-breast-cancer-gene-tests-180022078.html"><img src="http://l2.yimg.com/bt/api/res/1.2/94lCu8UF8oTJAV2lEoTwLQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/d1f04896cf25a913340f6a706700a121.jpg" width="130" height="86" alt="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" align="left" title="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" border="0" /></a>A ruling by the Supreme Court that human genes can&#039;t be patented is expected to increase access and drop the cost for tests for gene mutations that greatly raise the risk of developing breast or ovarian cancer.</p><br clear="all"/>http://news.yahoo.com/court-ruling-may-open-breast-cancer-gene-tests-180022078.htmlThu, 13 Jun 2013 19:35:35 -0400Associated Presscourt-ruling-may-open-breast-cancer-gene-tests-180022078<p><a href="http://news.yahoo.com/court-ruling-may-open-breast-cancer-gene-tests-180022078.html"><img src="http://l2.yimg.com/bt/api/res/1.2/94lCu8UF8oTJAV2lEoTwLQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/d1f04896cf25a913340f6a706700a121.jpg" width="130" height="86" alt="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" align="left" title="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" border="0" /></a>A ruling by the Supreme Court that human genes can&#039;t be patented is expected to increase access and drop the cost for tests for gene mutations that greatly raise the risk of developing breast or ovarian cancer.</p><br clear="all"/>As top court invalidates some gene patents, biotech has moved onBy Sharon Begley NEW YORK (Reuters) - The U.S. Supreme Court decision on Thursday to uphold patent protections for genetic material that has been changed in the laboratory but invalidate patents for purely natural DNA may seem like a partial setback for the biotech industry, but experts said it isn't: the industry has already moved on. ...http://news.yahoo.com/top-court-invalidates-gene-patents-biotech-moved-230732022.htmlThu, 13 Jun 2013 19:07:32 -0400Reuterstop-court-invalidates-gene-patents-biotech-moved-230732022News Summary: Myriad stock volatile on gene rulingROLLERCOASTER REACTION: Diagnostic test maker Myriad Genetics saw its shares jump 10 percent, then plunge. The volatility was triggered by the Supreme Court's mixed ruling on the validity of patents for ...http://news.yahoo.com/news-summary-myriad-stock-volatile-224626640.htmlThu, 13 Jun 2013 18:46:26 -0400Associated Pressnews-summary-myriad-stock-volatile-224626640High court ruling on gene patents lifts MyriadShares of diagnostic test maker Myriad Genetics Inc. surged Thursday after the Supreme Court handed the company a partial victory in a battle over validity of Myriad patents underlying its lucrative test ...http://news.yahoo.com/high-court-ruling-gene-patents-155411757.htmlThu, 13 Jun 2013 15:08:11 -0400Associated Presshigh-court-ruling-gene-patents-155411757Analysis: Biotech wheat furor shows GM food safety debate far from settled<p><a href="http://news.yahoo.com/analysis-biotech-wheat-furor-shows-gm-food-safety-210446592.html"><img src="http://l3.yimg.com/bt/api/res/1.2/yc0IrkFnfD0n5h_2z4NwZg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-06-10T213442Z_1_CBRE9591NXY00_RTROPTP_2_US-WHEAT-KOREA.JPG" width="130" height="86" alt="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" align="left" title="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" border="0" /></a>By Carey Gillam (Reuters) - The refusal of some foreign buyers to purchase U.S. wheat after an unapproved genetically modified strain was discovered growing in a farm field in Oregon is the latest demonstration that the issue of biotech food safety is far from settled. Japan and South Korea canceled purchases of U.S. wheat after the discovery of the experimental wheat developed by Monsanto Co. The furor erupted just days after a May 25 protest in cities around the world targeting Monsanto, the leading developer of crops with transgenic DNA. At the crux of the concerns is the question of ...</p><br clear="all"/>http://news.yahoo.com/analysis-biotech-wheat-furor-shows-gm-food-safety-210446592.htmlMon, 10 Jun 2013 17:12:14 -0400Reutersanalysis-biotech-wheat-furor-shows-gm-food-safety-210446592<p><a href="http://news.yahoo.com/analysis-biotech-wheat-furor-shows-gm-food-safety-210446592.html"><img src="http://l3.yimg.com/bt/api/res/1.2/yc0IrkFnfD0n5h_2z4NwZg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-06-10T213442Z_1_CBRE9591NXY00_RTROPTP_2_US-WHEAT-KOREA.JPG" width="130" height="86" alt="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" align="left" title="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" border="0" /></a>By Carey Gillam (Reuters) - The refusal of some foreign buyers to purchase U.S. wheat after an unapproved genetically modified strain was discovered growing in a farm field in Oregon is the latest demonstration that the issue of biotech food safety is far from settled. Japan and South Korea canceled purchases of U.S. wheat after the discovery of the experimental wheat developed by Monsanto Co. The furor erupted just days after a May 25 protest in cities around the world targeting Monsanto, the leading developer of crops with transgenic DNA. At the crux of the concerns is the question of ...</p><br clear="all"/>Gene flaws common in blacks with breast cancer<p><a href="http://news.yahoo.com/gene-flaws-common-blacks-breast-cancer-121520504.html"><img src="http://l1.yimg.com/bt/api/res/1.2/r1syDASV2Hdpc.Sg7s7keA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/c52bff20992bb412330f6a7067002ef9.jpg" width="130" height="86" alt="In this May 31, 2013 photo, breast cancer survivor Alicia Cook holds photos of family members who have also been afflicted by breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" align="left" title="In this May 31, 2013 photo, breast cancer survivor Alicia Cook holds photos of family members who have also been afflicted by breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" border="0" /></a>CHICAGO (AP) ? Gene flaws that raise the risk of breast cancer are surprisingly common in black women with the disease, according to the first comprehensive testing in this racial group. The study found that one-fifth of these women have BRCA mutations, a problem usually associated with women of Eastern European Jewish descent but recently highlighted by the plight of Angelina Jolie.</p><br clear="all"/>http://news.yahoo.com/gene-flaws-common-blacks-breast-cancer-121520504.htmlMon, 03 Jun 2013 08:47:09 -0400Associated Pressgene-flaws-common-blacks-breast-cancer-121520504<p><a href="http://news.yahoo.com/gene-flaws-common-blacks-breast-cancer-121520504.html"><img src="http://l1.yimg.com/bt/api/res/1.2/r1syDASV2Hdpc.Sg7s7keA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/c52bff20992bb412330f6a7067002ef9.jpg" width="130" height="86" alt="In this May 31, 2013 photo, breast cancer survivor Alicia Cook holds photos of family members who have also been afflicted by breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" align="left" title="In this May 31, 2013 photo, breast cancer survivor Alicia Cook holds photos of family members who have also been afflicted by breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" border="0" /></a>CHICAGO (AP) ? Gene flaws that raise the risk of breast cancer are surprisingly common in black women with the disease, according to the first comprehensive testing in this racial group. The study found that one-fifth of these women have BRCA mutations, a problem usually associated with women of Eastern European Jewish descent but recently highlighted by the plight of Angelina Jolie.</p><br clear="all"/>Advice for black women on breast cancer gene risk<p><a href="http://news.yahoo.com/advice-black-women-breast-cancer-gene-risk-200010535.html"><img src="http://l3.yimg.com/bt/api/res/1.2/IQXuyMvaKWQAC.5ySpGJZQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3B4b2ZmPTUwO3B5b2ZmPTA7cT04NTt3PTEzMA--/http://media.zenfs.com/en_us/News/ap_webfeeds/f5549e7f992eb412330f6a7067008a0f.jpg" width="130" height="86" alt="In this May 31, 2013, photo, breast cancer survivor Alicia Cook holds a letter from the University of Chicago informing her that test results showed she had the BRCA genetic defect linked to breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" align="left" title="In this May 31, 2013, photo, breast cancer survivor Alicia Cook holds a letter from the University of Chicago informing her that test results showed she had the BRCA genetic defect linked to breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" border="0" /></a>CHICAGO (AP) ? New research suggests that bad genes may be responsible for more breast cancer cases in black women than has been previously known. About 1 in 5 African-American women with the disease have an inherited mutation that drastically raises their risk for breast and ovarian cancer, according to a study released Monday.</p><br clear="all"/>http://news.yahoo.com/advice-black-women-breast-cancer-gene-risk-200010535.htmlMon, 03 Jun 2013 16:00:10 -0400Associated Pressadvice-black-women-breast-cancer-gene-risk-200010535<p><a href="http://news.yahoo.com/advice-black-women-breast-cancer-gene-risk-200010535.html"><img src="http://l3.yimg.com/bt/api/res/1.2/IQXuyMvaKWQAC.5ySpGJZQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3B4b2ZmPTUwO3B5b2ZmPTA7cT04NTt3PTEzMA--/http://media.zenfs.com/en_us/News/ap_webfeeds/f5549e7f992eb412330f6a7067008a0f.jpg" width="130" height="86" alt="In this May 31, 2013, photo, breast cancer survivor Alicia Cook holds a letter from the University of Chicago informing her that test results showed she had the BRCA genetic defect linked to breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" align="left" title="In this May 31, 2013, photo, breast cancer survivor Alicia Cook holds a letter from the University of Chicago informing her that test results showed she had the BRCA genetic defect linked to breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)" border="0" /></a>CHICAGO (AP) ? New research suggests that bad genes may be responsible for more breast cancer cases in black women than has been previously known. About 1 in 5 African-American women with the disease have an inherited mutation that drastically raises their risk for breast and ovarian cancer, according to a study released Monday.</p><br clear="all"/>Pluristem slumps as FDA suspends stem cell studyPluristem Therapeutics Inc. said Tuesday the Food and Drug Administration suspended a clinical trial of one of its stem cell therapies, sending the company's shares lower. Pluristem said one patient in ...http://news.yahoo.com/pluristem-slumps-fda-suspends-stem-164125737.htmlTue, 04 Jun 2013 12:41:25 -0400Associated Presspluristem-slumps-fda-suspends-stem-164125737Study finds strong genetic links for blacks with breast cancerBy Julie Steenhuysen CHICAGO (Reuters) - Researchers have been working for years to determine whether genetic glitches are driving high rates of especially deadly breast cancer in black women in the United States. Now, the most comprehensive genetic study yet found that one in five black women already diagnosed with breast cancer and referred for genetic counseling had at least one of 18 genetic mutations known to increase the risk of the disease. ...http://news.yahoo.com/study-finds-strong-genetic-links-blacks-breast-cancer-173352931.htmlMon, 03 Jun 2013 13:33:52 -0400Reutersstudy-finds-strong-genetic-links-blacks-breast-cancer-173352931Sen. Wyden warns gene-altered wheat could become trade problemWASHINGTON (Reuters) - The U.S. Agriculture Department must work with other agencies to ensure that the discovery of unapproved genetically engineered wheat in Oregon does not become an unfair barrier to trade, one of the state's U.S. Senators said on Friday. "The discovery of non-harvested, GE (genetically engineered) wheat should not be used by America's trading partners to erect spurious, protectionist trade barriers ... in the absence of scientific evidence indicating that Oregon exports contain this strain of wheat," Sen. Roy Wyden, a Democrat, wrote to USDA Secretary Tom Vilsack. ...http://news.yahoo.com/sen-wyden-warns-gene-altered-wheat-could-become-183553663.htmlFri, 31 May 2013 14:35:53 -0400Reuterssen-wyden-warns-gene-altered-wheat-could-become-183553663Analysis: Biotech's bull run starts to look frothyBy Deena Beasley (Reuters) - Biotech stocks are so hot that even some of the bulls are starting to find themselves on edge. An index of biotech drugmakers' shares has climbed nearly 50 percent in the past 12 months to all-time highs as the industry starts to launch drugs developed by identifying genes associated with disease - a revolution made possible by decoding the first human genome more than 10 years ago. ...http://news.yahoo.com/analysis-biotechs-bull-run-starts-look-frothy-110206899.htmlTue, 28 May 2013 08:16:04 -0400Reutersanalysis-biotechs-bull-run-starts-look-frothy-110206899Swiss billionaires buy Merck Serono HQ for biotech campus<p><a href="http://news.yahoo.com/swiss-billionaires-buy-merck-serono-hq-biotech-campus-134304063.html"><img src="http://l.yimg.com/bt/api/res/1.2/FrXw20KFGATsLbiJxltefg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-05-22T134917Z_1_CBRE94L12ED00_RTROPTP_2_MERCK-SERONO.JPG" width="130" height="86" alt="The new logo of bio pharmaceutical company Merck Serono SA is pictured outside the new headquarters in Geneva" align="left" title="The new logo of bio pharmaceutical company Merck Serono SA is pictured outside the new headquarters in Geneva" border="0" /></a>By Caroline Copley ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus. After selling the family business to German drugmaker Merck KGaA for $13.3 billion in 2006, the Harvard Business School graduate went on to win the America&#039;s Cup sailing prize for the second time. He and his former beauty queen wife Kirsty cut a high profile among the Swiss jet-set. ...</p><br clear="all"/>http://news.yahoo.com/swiss-billionaires-buy-merck-serono-hq-biotech-campus-134304063.htmlWed, 22 May 2013 09:43:04 -0400Reutersswiss-billionaires-buy-merck-serono-hq-biotech-campus-134304063<p><a href="http://news.yahoo.com/swiss-billionaires-buy-merck-serono-hq-biotech-campus-134304063.html"><img src="http://l.yimg.com/bt/api/res/1.2/FrXw20KFGATsLbiJxltefg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-05-22T134917Z_1_CBRE94L12ED00_RTROPTP_2_MERCK-SERONO.JPG" width="130" height="86" alt="The new logo of bio pharmaceutical company Merck Serono SA is pictured outside the new headquarters in Geneva" align="left" title="The new logo of bio pharmaceutical company Merck Serono SA is pictured outside the new headquarters in Geneva" border="0" /></a>By Caroline Copley ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus. After selling the family business to German drugmaker Merck KGaA for $13.3 billion in 2006, the Harvard Business School graduate went on to win the America&#039;s Cup sailing prize for the second time. He and his former beauty queen wife Kirsty cut a high profile among the Swiss jet-set. ...</p><br clear="all"/>UK tries out new model for gene testing in cancer patients<p><a href="http://news.yahoo.com/uk-tries-model-gene-testing-cancer-patients-143135493.html"><img src="http://l2.yimg.com/bt/api/res/1.2/c_ur3lU4G9PxzZxkvSDH2g--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-05-20T143135Z_1_CBRE94J14CR00_RTROPTP_2_SCIENCE-NANOMEDICINE.JPG" width="130" height="86" alt="A tray containing cancer cells sits on an optical microscope in the Nanomedicine Lab at UCL&#039;s School of Pharmacy in London" align="left" title="A tray containing cancer cells sits on an optical microscope in the Nanomedicine Lab at UCL&#039;s School of Pharmacy in London" border="0" /></a>By Kate Kelland LONDON (Reuters) - Britain launched a research program on Monday that should eventually allow all cancer patients to have access to the kind of genetic analysis that led Hollywood star Angelina Jolie to decide to undergo a double mastectomy. The project, involving the Institute of Cancer Research (ICR) in London, the U.S. gene sequencing firm Illumina, geneticists and cancer doctors, aims to find a way to allow more cancer genes be tested in more people. Researchers announcing the 2. ...</p><br clear="all"/>http://news.yahoo.com/uk-tries-model-gene-testing-cancer-patients-143135493.htmlMon, 20 May 2013 10:31:35 -0400Reutersuk-tries-model-gene-testing-cancer-patients-143135493<p><a href="http://news.yahoo.com/uk-tries-model-gene-testing-cancer-patients-143135493.html"><img src="http://l2.yimg.com/bt/api/res/1.2/c_ur3lU4G9PxzZxkvSDH2g--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-05-20T143135Z_1_CBRE94J14CR00_RTROPTP_2_SCIENCE-NANOMEDICINE.JPG" width="130" height="86" alt="A tray containing cancer cells sits on an optical microscope in the Nanomedicine Lab at UCL&#039;s School of Pharmacy in London" align="left" title="A tray containing cancer cells sits on an optical microscope in the Nanomedicine Lab at UCL&#039;s School of Pharmacy in London" border="0" /></a>By Kate Kelland LONDON (Reuters) - Britain launched a research program on Monday that should eventually allow all cancer patients to have access to the kind of genetic analysis that led Hollywood star Angelina Jolie to decide to undergo a double mastectomy. The project, involving the Institute of Cancer Research (ICR) in London, the U.S. gene sequencing firm Illumina, geneticists and cancer doctors, aims to find a way to allow more cancer genes be tested in more people. Researchers announcing the 2. ...</p><br clear="all"/>Affymetrix CFO Barabe to retire in JuneAffymetrix Chief Financial Officer Tim Barabe is planning to retire from his post next month. The genetic testing instrument business said Monday that it is promoting Gavin Wood to the position. Barabe's ...http://news.yahoo.com/affymetrix-cfo-barabe-retire-june-102937943.htmlMon, 20 May 2013 06:29:37 -0400Associated Pressaffymetrix-cfo-barabe-retire-june-102937943

Source: http://rss.news.yahoo.com/rss/biotech

joan crawford john goodman kendall marshall whitney houston news sylvia plath whitney houston autopsy results obama trayvon

Android App Allows Access to Court Documents

MGN Online

MGN Online

RENO, NV - Online access to court documents and information is now available for Android.

The Nevada Supreme Court launched an Android application that allows attorneys and the general public to have mobile access to court documents.

It includes a function that allows access to case documents, publicly filed briefs, motions, orders and opinions.

Users also have access to news items, court information and self-help court forms.

The name of the application is Supreme Court of Nevada, or NV Supreme Court.

Supreme Court of Nevada is available to download for free through Google Play.

Source: http://www.kolotv.com/home/headlines/Android-App-Allows-Access-to-Court-Documents--215594721.html

Javon Belcher express kindle fire Jenny Johnson olivier martinez ny lottery Ohio Lottery